References
- Tenenbein M. Toxicokinetics and toxicodynamics of iron poisoning. Toxicol Lett. 1998;102–103:653–656.
- Perrone J. Iron. In: Nelson LS, Howland MA, Lewin NA, et al., editors. Goldfrank’s toxicologic emergencies. 11th ed. New York: McGraw Hill Education; 2019.
- The Therapeutic Goods Administration. Australian register of therapeutic goods. Australian Product Information – Ferinject® (ferric carboxymaltose) solution for injection; 2022 [cited 2022 Jul 17]. Available from: https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2011-PI-02557-3&d=20220716172310101&d=20220717172310101
- Geisser P, Banke-Bochita J. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia. Drug Res. 2010;60:362–372.
- Biary R, Li L, Hoffman RS. Intravenous iron overdose: treat the patient not the number. Toxicol Commun. 2019;3(1):37–39.
- Beuhler MC, Wallace KL. Benign outcome with toxic serum iron levels following IV iron dextran overdose in three patients. Clin Toxicol. 2003;41(5):738–739.